March 21, 2018 / 4:54 PM / 2 months ago

BRIEF-Transgene To Announce Major Clinical Results In 2018

March 21 (Reuters) - TRANSGENE SA:

* TRANSGENE TO ANNOUNCE MAJOR CLINICAL RESULTS IN 2018 AND ACHIEVE PROMISING PROGRESS ON ITS NEW ONCOLYTIC VIRUSES

* CLINICAL RESULTS EXPECTED IN 2018 ON FIVE PRODUCTS

* CASH AVAILABLE AT YEAR-END 2017: €41.4 MILLION, COMPARED TO €56.2 MILLION AT THE END OF 2016

* NET LOSS OF €32.2 MILLION IN 2017, COMPARED TO A LOSS OF €25.2 MILLION IN 2016

* EXPECTS ITS CASH BURN FOR 2018 TO BE COMPARABLE TO 2017

* HAS THE FINANCIAL RESOURCES TO EXECUTE ITS STRATEGY THROUGH MID-2019. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below